Letter
Design and Synthesis of Redox Stable Analogues of Sunflower Trypsin Inhibitors (SFTI-1) on Solid Support, Potent Inhibitors of Matriptase
NCI, NIH.
These authors contributed equally to the work.
Current address: Intra-Cellular Therapies, Inc., New York, 10032.
Georgetown University Medical Center.
Current address: Shanghai Institute of Materia Medica, Shanghai 201203, China.
In papers with more than one author, the asterisk indicates the name of the author to whom inquiries about the paper should be addressed.
In memory of Dr Robert B. Dickson
Abstract

Matriptase is a member of the emerging class of type II transmembrane serine proteases. It was found that the sunflower trypsin inhibitor (SFTI-1), isolated from sunflower seeds, inhibits matriptase with a subnanomolar Ki of 0.92 nM. On the basis of this result, we designed and synthesized its proteolytically stable analogues, SFTI-2 and SFTI-3. SFTI-3 exhibited very good binding affinity to matriptase, and it was metabolically stable.
View: Full Text HTML | Hi-Res PDF
Tools
-
Add to Favorites
-
Download Citation
-
Email a Colleague -
Permalink
Order Reprints
Rights & Permissions
Citation Alerts
History
- Published In Issue January 04, 2007
- Received August 30, 2006
Cart




